Rates of BRCA1/2 mutation testing among young survivors of breast cancer.

Abstract excerpt

Guidelines in the United States recommend consideration of testing for mutations in the BRCA1 and BRCA2 genes for women diagnosed with breast cancer under age 45. Identification of mutations among survivors has implications for secondary prevention and familial risk reduction. Although only 10 % of breast cancers are diagnosed under age 45, there are approximately 2.8 million breast cancer survivors in the United...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age Factors
• Share to Breast Neoplasms
• Share to Genes, BRCA1